Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3β.
about
Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factorMicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling PathwayTransforming growth factor-β1 regulates epithelial-mesenchymal transition in association with cancer stem-like cells in a breast cancer cell lineRPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis.Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer.The expression and clinical significance of ribophorin II (RPN2) in human breast cancer.Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.The Roles of MicroRNAs in Breast CancerA novel platform to enable inhaled naked RNAi medicine for lung cancer.The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1.Hypoxia-Driven Mechanism of Vemurafenib Resistance in MelanomaRetracted: Tumor Protein D52-Like 2 Contributes to Proliferation of Breast Cancer CellsIdentification of target proteins involved in cochlear otosclerosis.RPN2 promotes colorectal cancer cell proliferation through modulating the glycosylation status of EGFRImmunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
P2860
Q21245752-1603EAFA-A14B-493B-A031-9465ADAFC15EQ28551191-4D2E11CD-369D-4099-90F0-6A04A28F28DBQ33756214-FCF1C30E-E54F-479D-B9AA-F9D867D271DEQ33805534-0E41251F-782B-4D1F-94FA-659DD548C022Q34103963-E773D4B8-8017-4A85-97D2-017B43F1969FQ34436450-C23FC7FE-0E4A-41F9-8CB0-73FD9E1CFF61Q34458532-77ECAAA1-F68D-40C5-BC4E-9B8F629B76C6Q34472128-1EA9BF24-941B-4E12-8895-48EDD3883B96Q34494956-AAF17673-AE4F-438D-B383-8E6CFB6665DFQ35366515-6F77DB58-BB48-498B-8B4B-C4AE22E87C34Q35818407-A8EC0BFD-87C7-4587-88B6-B3311F21D2C5Q37338963-47CBD3D3-D65A-45ED-B19B-582A38248516Q37706678-66F0C8A0-3274-4BF9-941B-1BFD227BD045Q38755819-8979D751-B8E4-44C2-927D-9AE0E472693CQ38915723-E092F96E-87AC-4AB8-8270-88A96E503256Q40667727-BF2129E1-AB72-4944-BDD8-1D1D9E39FA24Q42700759-405B9209-B2F4-4BB9-80AE-61A8ED9EF434Q58214193-26EBB9D3-4EC9-4C4D-B340-15CA9D1487D0
P2860
Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3β.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ribophorin II regulates breast ...... nctional suppression of GSK3β.
@en
Ribophorin II regulates breast ...... nctional suppression of GSK3β.
@nl
type
label
Ribophorin II regulates breast ...... nctional suppression of GSK3β.
@en
Ribophorin II regulates breast ...... nctional suppression of GSK3β.
@nl
prefLabel
Ribophorin II regulates breast ...... nctional suppression of GSK3β.
@en
Ribophorin II regulates breast ...... nctional suppression of GSK3β.
@nl
P2093
P2860
P356
P1433
P1476
Ribophorin II regulates breast ...... nctional suppression of GSK3β.
@en
P2093
Fumitaka Takeshita
Kikuya Kato
Kimi Honma
Masaya Ono
Ryou-u Takahashi
Takahiro Ochiya
P2860
P2888
P356
10.1038/SREP02474
P407
P577
2013-01-01T00:00:00Z